Utilization of Quantiferon-Cytomegalovirus Assay to Assess the Risk of CMV Disease and Guide Duration of Antiviral Prophylaxis in CMV-Mismatched Solid Organ Transplant Recipients

Ganciclovir Susceptibilities of Cytomegalovirus (CMV) Isolates from Solid Organ Transplant Recipients with CMV Viremia after Antiviral Prophylaxis

The Journal of Infectious Diseases ◽

10.1093/infdis/168.2.332 ◽

1993 ◽

Vol 168 (2) ◽

pp. 332-335 ◽

Cited By ~ 59

Author(s):

G. Boivin ◽

A. Erice ◽

D. D. Crane ◽

D. L. Dunn ◽

H. H. Balfour

Keyword(s):

Organ Transplant ◽

Solid Organ Transplant ◽

Solid Organ ◽

Antiviral Prophylaxis ◽

Transplant Recipients ◽

CMV-HYPERIMMUNE GLOBULIN FOR TREATMENT OF RECURRENT CMV DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS

Transplantation Journal ◽

10.1097/00007890-201007272-01259 ◽

2010 ◽

Vol 90 ◽

pp. 658

Author(s):

S. abou antoun ◽

J. fields ◽

M. Sandid ◽

E. wehbe ◽

M. assi

Keyword(s):

Organ Transplant ◽

Solid Organ Transplant ◽

Solid Organ ◽

Transplant Recipients ◽

Hyperimmune Globulin ◽

Delayed onset CMV disease in solid organ transplant recipients

Transplant Immunology ◽

10.1016/j.trim.2008.12.004 ◽

2009 ◽

Vol 21 (1) ◽

pp. 1-9 ◽

Cited By ~ 28

Author(s):

Shahid Husain ◽

Carolynn E. Pietrangeli ◽

Adriana Zeevi

Keyword(s):

Organ Transplant ◽

Solid Organ Transplant ◽

Solid Organ ◽

Transplant Recipients ◽

Delayed Onset ◽

Cytomegalovirus (CMV) Glycoprotein B Genotypes and Response to Antiviral Therapy, in Solid‐Organ–Transplant Recipients with CMV Disease

The Journal of Infectious Diseases ◽

10.1086/377002 ◽

2003 ◽

Vol 188 (4) ◽

pp. 581-584 ◽

Cited By ~ 47

Author(s):

Atul Humar ◽

Deepali Kumar ◽

Christian Gilbert ◽

Guy Boivin

Keyword(s):

Antiviral Therapy ◽

Organ Transplant ◽

Solid Organ Transplant ◽

Glycoprotein B ◽

Solid Organ ◽

Transplant Recipients ◽

Late-Onset Cytomegalovirus Disease as a Significant Complication in Solid Organ Transplant Recipients Receiving Antiviral Prophylaxis: A Call to Heed the Mounting Evidence

Clinical Infectious Diseases ◽

10.1086/427506 ◽

2005 ◽

Vol 40 (5) ◽

pp. 704-708 ◽

Cited By ~ 75

Author(s):

N. Singh

Keyword(s):

Late Onset ◽

Organ Transplant ◽

Solid Organ Transplant ◽

Solid Organ ◽

Antiviral Prophylaxis ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Significant Complication ◽

Clinical Utility of Cytomegalovirus Viral Load Testing for Predicting CMV Disease in D+/R- Solid Organ Transplant Recipients

American Journal of Transplantation ◽

10.1111/j.1600-6143.2004.00391.x ◽

2004 ◽

Vol 4 (4) ◽

pp. 644-649 ◽

Cited By ~ 79

Author(s):

Atul Humar ◽

Carlos Paya ◽

Mark D. Pescovitz ◽

Ed Dominguez ◽

Kenneth Washburn ◽

...

Keyword(s):

Viral Load ◽

Clinical Utility ◽

Organ Transplant ◽

Solid Organ Transplant ◽

Solid Organ ◽

Load Testing ◽

Transplant Recipients ◽

Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients

Transplant International ◽

10.1111/j.1432-2277.2011.01285.x ◽

2011 ◽

Vol 24 (9) ◽

pp. 920-931 ◽

Cited By ~ 20

Author(s):

Corinna La Rosa ◽

Ajit P. Limaye ◽

Aparna Krishnan ◽

Gideon Blumstein ◽

Jeff Longmate ◽

...

Keyword(s):

Organ Transplant ◽

Solid Organ Transplant ◽

Primary Response ◽

Solid Organ ◽

Antiviral Prophylaxis ◽

Transplant Recipients ◽

ChemInform Abstract: Delayed Onset CMV Disease in Solid Organ Transplant Recipients

ChemInform ◽

10.1002/chin.200949265 ◽

2009 ◽

Vol 40 (49) ◽

Author(s):

Shahid Husain ◽

Carolynn E. Pietrangeli ◽

Adriana Zeevi

Keyword(s):

Organ Transplant ◽

Solid Organ Transplant ◽

Solid Organ ◽

Transplant Recipients ◽

Delayed Onset ◽

Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

American Journal of Transplantation ◽

10.1111/j.1600-6143.2009.02617.x ◽

2009 ◽

Vol 9 (5) ◽

pp. 1205-1213 ◽

Cited By ~ 118

Author(s):

A. Åsberg ◽

A. Humar ◽

A. G. Jardine ◽

H. Rollag ◽

M. D. Pescovitz ◽

...

Keyword(s):

Organ Transplant ◽

Solid Organ Transplant ◽

Solid Organ ◽

Transplant Recipients ◽

Long Term Outcomes ◽

Disease Treatment ◽

Clinical Utility of Molecular Surveillance for Cytomegalovirus After Antiviral Prophylaxis in High-Risk Solid Organ Transplant Recipients

Transplantation Journal ◽

10.1097/tp.0b013e31822fa4b7 ◽

2011 ◽

pp. 1 ◽

Cited By ~ 3

Author(s):

Luiz F. Lisboa ◽

Jutta K. Preiksaitis ◽

Atul Humar ◽

Deepali Kumar

Keyword(s):

High Risk ◽

Clinical Utility ◽

Organ Transplant ◽

Solid Organ Transplant ◽

Solid Organ ◽

Antiviral Prophylaxis ◽

Transplant Recipients ◽

Molecular Surveillance ◽